Calamos Wealth Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-4,428
| Closed | -$341K | – | 331 |
|
|
2023
Q2 | $341K | Buy |
4,428
+277
| +7% | +$21.3K | 0.03% | 235 |
|
|
2023
Q1 | $344K | Sell |
4,151
-188
| -4% | -$15.6K | 0.03% | 242 |
|
|
2022
Q4 | $373K | Buy |
+4,339
| New | +$373K | 0.03% | 229 |
|
|
2017
Q2 | – | Sell |
-39,260
| Closed | -$2.67M | – | 228 |
|
|
2017
Q1 | $2.67M | Buy |
39,260
+5,533
| +16% | +$376K | 0.4% | 76 |
|
|
2016
Q4 | $2.42M | Sell |
33,727
-5,063
| -13% | -$363K | 0.39% | 78 |
|
|
2016
Q3 | $3.07M | Buy |
38,790
+1,627
| +4% | +$129K | 0.52% | 61 |
|
|
2016
Q2 | $3.1M | Buy |
37,163
+10,492
| +39% | +$875K | 0.55% | 54 |
|
|
2016
Q1 | $2.45M | Buy |
26,671
+4,581
| +21% | +$421K | 0.47% | 62 |
|
|
2015
Q4 | $2.24M | Buy |
22,090
+1,131
| +5% | +$114K | 0.45% | 66 |
|
|
2015
Q3 | $2.06M | Buy |
20,959
+1,155
| +6% | +$113K | 0.49% | 60 |
|
|
2015
Q2 | $2.32M | Buy |
19,804
+10,536
| +114% | +$1.23M | 0.55% | 52 |
|
|
2015
Q1 | $909K | Sell |
9,268
-5,178
| -36% | -$508K | 0.23% | 144 |
|
|
2014
Q4 | $1.36M | Sell |
14,446
-4,417
| -23% | -$416K | 0.39% | 98 |
|
|
2014
Q3 | $2.01M | Sell |
18,863
-10,856
| -37% | -$1.16M | 0.58% | 58 |
|
|
2014
Q2 | $2.46M | Buy |
29,719
+60
| +0.2% | +$4.98K | 0.7% | 43 |
|
|
2014
Q1 | $2.1M | Buy |
29,659
+6,545
| +28% | +$464K | 0.62% | 54 |
|
|
2013
Q4 | $1.74M | Sell |
23,114
-625
| -3% | -$47K | 0.53% | 78 |
|
|
2013
Q3 | $1.49M | Sell |
23,739
-12,336
| -34% | -$775K | 0.49% | 83 |
|
|
2013
Q2 | $1.85M | Buy |
+36,075
| New | +$1.85M | 0.65% | 55 |
|